-+ 0.00%
-+ 0.00%
-+ 0.00%

LUMOSITY ANNOUNCES FDA CLEARANCE OF LUMOSITYRX, A PRESCRIPTION DIGITAL THERAPEUTIC FOR ADULTS WITH ADHD

Reuters·12/10/2025 15:00:10

Please log in to view news